Literature DB >> 9466753

Impact of strain heterogeneity on Lyme disease serology in Europe: comparison of enzyme-linked immunosorbent assays using different species of Borrelia burgdorferi sensu lato.

U Hauser1, H Krahl, H Peters, V Fingerle, B Wilske.   

Abstract

For the standardization of serological tests for Lyme borreliosis (LB) in Europe, the influence of the heterogeneity of Borrelia burgdorferi sensu lato must be assessed in detail. For this study four immunoglobulin M (IgM) and IgG enzyme-linked immunosorbent assays (ELISAs) with octyl-beta-D-glucopyranoside extracts of strains PKo (Borrelia afzelii), PBi (Borrelia garinii), and PKa2 and B31 (both B. burgdorferi sensu stricto) were compared. Strains PKo, PBi, and PKa2 at the passages used for antigen preparations abundantly expressed outer surface protein C (OspC), whereas strain B31 at the passage used for antigen preparation did not express OspC. Sera (all from Germany) from 222 patients with clinically defined LB of all stages, 133 blood donors, and 458 forest workers were tested. None of the forest workers had symptoms consistent with LB at the time that the samples were collected. For IgM tests, receiver operating characteristic curves demonstrated that discrimination between sera from patients and blood donors was best with strain PKo and worst with strain B31. The discriminatory abilities of the four IgG ELISAs were similar in a diagnostically reasonable specificity range (90 to 100%). More than 20% of the sera from forest workers reacted strongly in the PKo IgG ELISA (optical density value, >1.5; other assays, less than 8%). Western blots of the sera with the most discrepant ELISA results revealed almost exclusive reactivity with p17. This highly immunogenic antigen is only expressed by strain PKo. This observation might be important for the development of assays enabling discrimination between asymptomatic or previous infection and active disease.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9466753      PMCID: PMC104554     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  41 in total

1.  Distribution and molecular analysis of Lyme disease spirochetes, Borrelia burgdorferi, isolated from ticks throughout California.

Authors:  T G Schwan; M E Schrumpf; R H Karstens; J R Clover; J Wong; M Daugherty; M Struthers; P A Rosa
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

2.  Immunoblot using recombinant antigens derived from different genospecies of Borrelia burgdorferi sensu lato.

Authors:  B Wilske; V Fingerle; V Preac-Mursic; S Jauris-Heipke; A Hofmann; H Loy; H W Pfister; D Rössler; E Soutschek
Journal:  Med Microbiol Immunol       Date:  1994-02       Impact factor: 3.402

3.  Phenotypic analysis of outer surface protein C (OspC) of Borrelia burgdorferi sensu lato by monoclonal antibodies: relationship to genospecies and OspA serotype.

Authors:  B Wilske; S Jauris-Heipke; R Lobentanzer; I Pradel; V Preac-Mursic; D Rössler; E Soutschek; R C Johnson
Journal:  J Clin Microbiol       Date:  1995-01       Impact factor: 5.948

4.  An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis.

Authors:  B Wilske; V Preac-Mursic; U B Göbel; B Graf; S Jauris; E Soutschek; E Schwab; G Zumstein
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

5.  Comparison of different strains of Borrelia burgdorferi sensu lato used as antigens in enzyme-linked immunosorbent assays.

Authors:  L A Magnarelli; J F Anderson; R C Johnson; R B Nadelman; G P Wormser
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

6.  Immunological and molecular polymorphisms of OspC, an immunodominant major outer surface protein of Borrelia burgdorferi.

Authors:  B Wilske; V Preac-Mursic; S Jauris; A Hofmann; I Pradel; E Soutschek; E Schwab; G Will; G Wanner
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

7.  Recombinant immunoblot in the serodiagnosis of Lyme borreliosis. Comparison with indirect immunofluorescence and enzyme-linked immunosorbent assay.

Authors:  B Wilske; V Fingerle; P Herzer; A Hofmann; G Lehnert; H Peters; H W Pfister; V Preac-Mursic; E Soutschek; K Weber
Journal:  Med Microbiol Immunol       Date:  1993-11       Impact factor: 3.402

8.  Azithromycin versus penicillin V for the treatment of early Lyme borreliosis.

Authors:  K Weber; B Wilske; V Preac-Mursic; R Thurmayr
Journal:  Infection       Date:  1993 Nov-Dec       Impact factor: 3.553

9.  Monoclonal antibodies for identification of Borrelia afzelii sp. nov. associated with late cutaneous manifestations of Lyme borreliosis.

Authors:  M M Canica; F Nato; L du Merle; J C Mazie; G Baranton; D Postic
Journal:  Scand J Infect Dis       Date:  1993

10.  Different genospecies of Borrelia burgdorferi are associated with distinct clinical manifestations of Lyme borreliosis.

Authors:  A P van Dam; H Kuiper; K Vos; A Widjojokusumo; B M de Jongh; L Spanjaard; A C Ramselaar; M D Kramer; J Dankert
Journal:  Clin Infect Dis       Date:  1993-10       Impact factor: 9.079

View more
  18 in total

1.  Validity of interpretation criteria for standardized Western blots (immunoblots) for serodiagnosis of Lyme borreliosis based on sera collected throughout Europe.

Authors:  U Hauser; G Lehnert; B Wilske
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Identifying diagnostic peptides for lyme disease through epitope discovery.

Authors:  G A Kouzmitcheva; V A Petrenko; G P Smith
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

Review 3.  Occupational risk of Lyme disease: an epidemiological review.

Authors:  J D Piacentino; B S Schwartz
Journal:  Occup Environ Med       Date:  2002-02       Impact factor: 4.402

4.  Differential immune response to the variable surface loop antigen of P66 of Borrelia burgdorferi sensu lato species in geographically diverse populations of lyme borreliosis patients.

Authors:  Katharina Ornstein; Yngve Ostberg; Jonas Bunikis; Laila Noppa; Johan Berglund; Ragnar Norrby; Sven Bergström
Journal:  Clin Diagn Lab Immunol       Date:  2002-11

5.  Species-specific serodiagnosis of Lyme arthritis and neuroborreliosis due to Borrelia burgdorferi sensu stricto, B. afzelii, and B. garinii by using decorin binding protein A.

Authors:  Tero Heikkilä; Ilkka Seppälä; Harri Saxen; Jaana Panelius; Heta Yrjänäinen; Pekka Lahdenne
Journal:  J Clin Microbiol       Date:  2002-02       Impact factor: 5.948

6.  A decrease in the immunoglobulin G antibody response against the VlsE protein of Borrelia burgdorferi sensu lato correlates with the resolution of clinical signs in antibiotic-treated patients with early Lyme disease.

Authors:  Antonella Marangoni; Vittorio Sambri; Silvia Accardo; Francesca Cavrini; Valeria Mondardini; Alessandra Moroni; Elisa Storni; Roberto Cevenini
Journal:  Clin Vaccine Immunol       Date:  2006-04

7.  DNA microarray assessment of putative Borrelia burgdorferi lipoprotein genes.

Authors:  Fang Ting Liang; F Kenneth Nelson; Erol Fikrig
Journal:  Infect Immun       Date:  2002-06       Impact factor: 3.441

Review 8.  Diagnosis of lyme borreliosis.

Authors:  Maria E Aguero-Rosenfeld; Guiqing Wang; Ira Schwartz; Gary P Wormser
Journal:  Clin Microbiol Rev       Date:  2005-07       Impact factor: 26.132

9.  Similarities in murine infection and immune response to Borrelia bissettii and Borrelia burgdorferi sensu stricto.

Authors:  Brian F Leydet; Fang Ting Liang
Journal:  Microbiology       Date:  2015-09-28       Impact factor: 2.777

10.  Borrelia burgdorferi VlsE antigen for the serological diagnosis of Lyme borreliosis.

Authors:  A Marangoni; A Moroni; S Accardo; R Cevenini
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-01-16       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.